APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,017,313 | +29.0% | 76,066 | +1.1% | 0.76% | +19.5% |
Q4 2022 | $3,889,471 | +2.8% | 75,217 | +35.8% | 0.64% | -2.0% |
Q3 2022 | $3,783,000 | -35.8% | 55,384 | -57.5% | 0.65% | -35.3% |
Q2 2022 | $5,894,000 | -10.9% | 130,340 | +0.1% | 1.00% | +19.1% |
Q1 2022 | $6,616,000 | -36.9% | 130,208 | -41.3% | 0.84% | -23.7% |
Q4 2021 | $10,491,000 | +104.0% | 221,901 | +42.2% | 1.11% | +107.5% |
Q3 2021 | $5,143,000 | – | 156,031 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |